- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Oncologists Lead on Reform, Ex CMS Head Says
Oncologists are at the forefront of payment and delivery reforms sweeping medicine today, a former head of Medicare said.
Oncologists are at the forefront of payment and delivery reforms sweeping medicine today, a former head of Medicare said here Monday.
Innovations in cancer care delivery -- such as oncology patient-centered medical homes -- are blazing the trail for all specialists, said Mark McClellan, MD, PhD, director of the Health Care Innovation and Value Initiative at the Brookings Institution in Washington.
"If you look at oncology care, I think some of the most important changes in provider payment reform are actually being led in cancer care," McClellan said at the Institute of Medicine's National Cancer Policy Summit. "This is a place to look for what could be a model for reforms in payments that would affect other parts of our healthcare system, other specialties."
McClellan is involved in a project at Brookings to conduct a review of payment reform activities in conjunction with the Center for Medicare and Medicaid Innovation. "We're finding a lot of activity related to cancer," he said.
Read the full story here: http://bit.ly/1cOrcqC
Source: Med Page Today
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
